Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.80p
   
  • Change Today:
      0.50p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.10p
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 267,919
  • Market Cap: £34.19m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £101,215
Lisa Baderoon 583,963 £39,710
Tim Franklin 525,000 £35,700

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,707,347
Luca & Associates AG 22,000,000 £1,496,000
Invesco Ltd 17,872,341 £1,215,319
Aviva Investors Global 11,285,180 £767,392
Alora Pharmaceuticals LLC 10,909,091 £741,818
M&G Investments 7,600,000 £516,800
Prudential plc 7,600,000 £516,800
Capital Income Builder 4,870,367 £331,185
Dr R Zimmer 4,551,553 £309,506
Odey Asset Management 3,433,319 £233,466
Rhone Trustees (Switzerland) SA 3,386,000 £230,248
Pictet Overseas Trust Corporation Limited 3,287,500 £223,550

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 6.80p
Change Today 0.50p
% Change 7.94 %
52 Week High 17.60p
52 Week Low 1.10p
Volume 267,919
Shares Issued 502.72m
Market Cap £34.19m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 03-Dec-2025

Time Volume / Share Price
09:07 290 @ 6.14p
09:06 147 @ 6.78p
09:06 395 @ 6.78p
09:01 600 @ 6.78p
08:57 37,605 @ 6.50p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page